Strategies to develop radiomics and machine learning models for lung cancer stage and histology prediction using small data samples.


Journal

Physica medica : PM : an international journal devoted to the applications of physics to medicine and biology : official journal of the Italian Association of Biomedical Physics (AIFB)
ISSN: 1724-191X
Titre abrégé: Phys Med
Pays: Italy
ID NLM: 9302888

Informations de publication

Date de publication:
Oct 2021
Historique:
received: 03 04 2021
revised: 21 08 2021
accepted: 28 08 2021
pubmed: 15 9 2021
medline: 3 11 2021
entrez: 14 9 2021
Statut: ppublish

Résumé

Predictive models based on radiomics and machine-learning (ML) need large and annotated datasets for training, often difficult to collect. We designed an operative pipeline for model training to exploit data already available to the scientific community. The aim of this work was to explore the capability of radiomic features in predicting tumor histology and stage in patients with non-small cell lung cancer (NSCLC). We analyzed the radiotherapy planning thoracic CT scans of a proprietary sample of 47 subjects (L-RT) and integrated this dataset with a publicly available set of 130 patients from the MAASTRO NSCLC collection (Lung1). We implemented intra- and inter-sample cross-validation strategies (CV) for evaluating the ML predictive model performances with not so large datasets. We carried out two classification tasks: histology classification (3 classes) and overall stage classification (two classes: stage I and II). In the first task, the best performance was obtained by a Random Forest classifier, once the analysis has been restricted to stage I and II tumors of the Lung1 and L-RT merged dataset (AUC = 0.72 ± 0.11). For the overall stage classification, the best results were obtained when training on Lung1 and testing of L-RT dataset (AUC = 0.72 ± 0.04 for Random Forest and AUC = 0.84 ± 0.03 for linear-kernel Support Vector Machine). According to the classification task to be accomplished and to the heterogeneity of the available dataset(s), different CV strategies have to be explored and compared to make a robust assessment of the potential of a predictive model based on radiomics and ML.

Identifiants

pubmed: 34521016
pii: S1120-1797(21)00298-2
doi: 10.1016/j.ejmp.2021.08.015
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

13-22

Informations de copyright

Copyright © 2021 Associazione Italiana di Fisica Medica. Published by Elsevier Ltd. All rights reserved.

Auteurs

L Ubaldi (L)

Physics Department, University of Pisa, Pisa, Italy; National Institute for Nuclear Physics (INFN), Pisa Division, Pisa, Italy.

V Valenti (V)

REM Radiation Therapy Center, Viagrande (CT), I-95029 Catania, Italy.

R F Borgese (RF)

Physics and Chemistry Department "Emilio Segrè", University of Palermo, Palermo, Italy; National Institute for Nuclear Physics (INFN), Catania Division, Catania, Italy.

G Collura (G)

Physics and Chemistry Department "Emilio Segrè", University of Palermo, Palermo, Italy; National Institute for Nuclear Physics (INFN), Catania Division, Catania, Italy.

M E Fantacci (ME)

Physics Department, University of Pisa, Pisa, Italy; National Institute for Nuclear Physics (INFN), Pisa Division, Pisa, Italy.

G Ferrera (G)

Radiation Oncology, ARNAS-Civico Hospital, Palermo, Italy.

G Iacoviello (G)

Medical Physics Department, ARNAS-Civico Hospital, Palermo, Italy.

B F Abbate (BF)

Medical Physics Department, ARNAS-Civico Hospital, Palermo, Italy.

F Laruina (F)

Physics Department, University of Pisa, Pisa, Italy; National Institute for Nuclear Physics (INFN), Pisa Division, Pisa, Italy.

A Tripoli (A)

REM Radiation Therapy Center, Viagrande (CT), I-95029 Catania, Italy.

A Retico (A)

National Institute for Nuclear Physics (INFN), Pisa Division, Pisa, Italy.

M Marrale (M)

Physics and Chemistry Department "Emilio Segrè", University of Palermo, Palermo, Italy; National Institute for Nuclear Physics (INFN), Catania Division, Catania, Italy.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH